Athero Review - Issue 1/2019
Guidelines
7
Nutraceuticals with hypolipidemic effect in clinical practice: a summary statement of the International expert panel of lipidologists prepared by the committee of the Czech society for atherosclerosis
Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová
19
An initiative to establish apheresis centers: indications for and performance of lipoprotein apheresis in the Czech Republic
Vladimír Bláha, Milan Bláha, Jan Piťha, Michal Vrablík
Reviews
30
Lysosomal acid lipase deficiency in differential diagnosis of familial hypercholesterolemia
Zuzana Urbanová, Věra Malinová
35
Therapy of dyslipidaemia in patient with muscular dystrophy: case report
Ľubica Cibičková, David Karásek
38
Severe mixed dyslipidemia as a manifestation of hematological disease: case report
Martin Šatný, Michal Vrablík, Janka Franeková, Jan Kovář
44
Psoriasis as a risk factor for cardiovascular events: case report
Branislav Vohnout, Jana Lisičanová, Andrea Havranová
49
Intensive management of dyslipidemia in very high-risk patients with PCSK9 inhibitors
Viera Doničová, Martina Gáborová
clinical studies
53
Athero Review
2019 Číslo 1
Najčítanejšie v tomto čísle
- Nutraceuticals with hypolipidemic effect in clinical practice: a summary statement of the International expert panel of lipidologists prepared by the committee of the Czech society for atherosclerosis
- Lysosomal acid lipase deficiency in differential diagnosis of familial hypercholesterolemia
- Therapy of dyslipidaemia in patient with muscular dystrophy: case report
- Psoriasis as a risk factor for cardiovascular events: case report